School of Medicine Faculty of Medicine Internal Medicine 2(Divisions of Endocrinology & Metabolism Respiratory Medicine &Hepatology)
Professor
藤澤 朋幸
FUJISAWA Tomoyuki

Last updated: 2026/06/05
Basic information on teaching staff
Career
1997/4/- Hamamatsu University School of Medicine Second Division, Department of Internal Medicine Resident
2007/4/- University of California Davis Post doctoral fellow
2009/11/- Jichi Medical University Department of Pulmonary Medicine Assistant Professor
2010/4/- Hamamatsu University School of Medicine Department of Laboratory Medicine Assistant Professor
2013/4/- Hamamatsu University School of Medicine Second Division, Department of Internal Medicine Assistant Professor
2024/4/1- Hamamatsu University School of Medicine Second Division, Department of Internal Medicine senior assistant professor
2026/4/1- Hamamatsu University School of Medicine Second Division, Department of Internal Medicine Professor
Academic degrees
MD, PhD Hamamatsu University School of Medicine
Research Areas
Life Science - Respiratory medicine
Research keywords
Interstitial lung diseases, airway epithelial cells, Innate immunity, Mucociliary transport
Subject of research
[1]. Exploration of pathogenesis and novel markers for myositis-associated interstitial lung disease
[2]. Biology of airway epithelial cells, Analysis of airway host defense, mucociliary transport
Proposed theme of joint or funded research
[1]. Analysis of airway ciliary function on SARS-CoV-2 infection
Research Projects (Competitive Research Funds)
[1]. Impairment of airway ciliary function in obese
[2]. Analysis of airway mucociliary transport via Toll-like receptors pathway
Research activities
Papers
[1]. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis.
Respiratory investigation [Volume]64 [Issue]2 [Page]101367 (2026/) [Reviewed] Yes [DOI]
[2]. Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.
Radiology. Cardiothoracic imaging [Volume]8 [Issue]1 [Page]e250190 (2026/) [Reviewed] Yes [DOI]
[3]. Amiodarone-Induced Pneumonia Without Foamy Macrophages in the BALF: A Diagnostic Challenge Unveiled by Cryobiopsy
Respirol Case Rep (2026/) [Reviewed] Yes
[4]. Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD
Scientific reports (2026/) [Reviewed] Yes
[5]. Psychological palliative care for patients with interstitial lung disease in Japan: A secondary analysis of a National Survey of Japanese Respiratory Physicians
Respiratory investigation (2026/) [Reviewed] Yes
Bibliography
[1]. 2025/11/ 【症状・ケアニーズを捉える 呼吸器疾患のアドバンスト緩和ケア】非がん性呼吸器疾患における緩和ケアの現状とニード (株)青海社
[2]. 2025/5/ 【間質性肺炎と肺がんのMDD-専門家チームで進める"最適化"】間質性肺炎 総論 MDDにおける呼吸器内科医と各専門医とのかかわり方 膠原病内科医との連携のポイント (株)医学書院
[3]. 2025/5/ 【びまん性肺疾患の新知見】その他の治療 間質性肺疾患における緩和医療 (有)科学評論社
[4]. 2025/1/ 抗MDA5抗体陽性皮膚筋炎関連間質性肺疾患におけるインターフェロン (有)科学評論社
[5]. 2023/1/ ABPM/SAFS (有)科学評論社
Research presentations
[1]. 2025/11/11 ILD in autoimmune disease: New insights in idiopathic inflammatory myopathy-associated ILD 29th Congress of Asian Pacific Society of Respirology
[2]. 2025/10/25 間質性肺疾患における緩和医療の現状とニード 第35回 日本呼吸ケア・リハビリテーション学会 学術集会
[3]. 2025/9/25 Obesity-induced airway ciliary dysfunction - Its potential role in the severity of COVID-19 - The 22nd Kyungpook-Hamamatsu Joint Medical Symposium
[4]. 2025/9/21 間質性肺疾患における緩和ケア 〜現状とニード〜 第5回 日本びまん性肺疾患研究会
[5]. 2025/8/25 Obesity-induced airway ciliary dysfunction - Its potential role in the severity of COVID-19 - SRM symposium
Prizes
[1]. 2019/ 第59回日本呼吸器学会学術講演会演題賞 優秀賞
[2]. 2010/ 第15回浜松医科大学同窓会学術奨励賞
Memberships of academic societies
[1]. 日本内科学会
[2]. 日本呼吸器学会
[3]. 日本アレルギー学会
[4]. 日本感染症学会
[5]. 日本サルコイドーシス学会
Committee Career
[1]. 2025/4/- 日本結核・非結核性抗酸菌症学会 代議員
[2]. 2025/4/- 日本サルコイドーシス/肉芽腫性疾患学会 評議員
[3]. 2022/1/17- Japanese Society of Allergology 代議員
Educational activities
Allotted class
[1]. 呼吸器内科学 抗酸菌感染症
[2]. 病態生理学
Social activities
Social Contribution
[1]. 2025/3/9- 2025/3/9 間質性肺炎 肺線維症 患者勉強会
[2]. 2024/2/15- 2024/2/15 完全マスター!! 気管支喘息の治療と自己管理